INTRODUCTION
A number of transmembrane proteins can also be found in soluble form as a result of a post-translational proteolytic processing event (reviewed in Ehlers and Riordan, 1991b) . Proteins that fall into this category are functionally diverse, including receptors and receptor ligands, cell-adhesion molecules, leucocyte antigens, viral membrane proteins and ectoenzymes. Probably the most notable of this type of protein is the amyloid precursor protein, the normal post-translational cleavage of which by a putative secretase activity may be defective in Alzheimer's disease (Esch et al., 1990; Selkoe, 1990; Wang et al., 1991) . Although a significant number and variety of transmembrane proteins are now known to be released by proteolysis in an active form, little is known about the secretase activities responsible for these processes, and such proteolytic activities may prove to be novel targets for therapeutic intervention.
Angiotension-converting enzyme (ACE; peptidyl dipeptidase A; EC 3.4.15.1) is a widely distributed cell-surface peptidase which plays a key role in the control of blood pressure and fluid and electrolyte homoeostasis (Soffer, 1976) . However, ACE does not always co-localize with other components of the reninangiotensin system and the enzyme displays a broad substrate specificity, which has led to ACE being implicated in a number of other processes including immunity, reproduction and neuropeptide metabolism (reviewed in Ehlers and Riordan, 1989; Hooper, 1991) . In mammals ACE exists as two distinct isoenzymes. The endothelial isoenzyme (Mr 180000 in the pig) is present throughout the body and is composed of two highly similar domains, each of which bears a functional catalytic site EGTA inhibited the secretase by a maximum of 15 % at a concentration of 10 mM. The inhibition of EDTA was reactivated substantially (83 %) by Mg2+ ions, and partially (34 % and 29 %) by Zn2+ and Mn2+ ions respectively. This EDTA-sensitive secretase activity was also present in microsomal membranes prepared from pig lung and testis, and from human lung and placenta, but was absent from human kidney and human and pig intestinal brush-border membranes. The form of ACE released from the microvillar membrane by the secretase co-migrated on SDS/PAGE with ACE purified from pig plasma, thus the action and location of the secretase would be consistent with it possibly having a role in the post-translational proteolytic cleavage of membrane-bound ACE to generate the soluble form found in blood, amniotic fluid, seminal plasma and other body fluids. (Soubrier et al., 1988; Ehlers and Riordan, 1991a; Wei et al., 1991b Wei et al., , 1992 Williams et al., 1992) . The other isoenzyme (Mr 110000 in the pig) is found exclusively in the testis and, with the exception of approx. 67 amino acids at the N-terminus, is identical to the C-terminal domain of endothelial ACE, thus containing only a single catalytic site (Lattion et al., 1989) .
The observation that both the hydrophilic, trypsin-solubilized and amphipathic, detergent-solubilized forms ofpig kidney ACE, which differ in Mr by approx. 10000, possessed identical Nterminal sequences led us to propose that ACE was not anchored in the membrane by an uncleaved N-terminal signal sequence but was probably attached via its C-terminus . The cDNA-predicted amino-acid sequence of endothelial ACE contains, apart from the cleavable N-terminal signal sequence, only one other region of high hydrophobicity which could possibly traverse the lipid bilayer and this is located 30 residues from the C-terminus (Soubrier et al., 1988) . Expression in Chinese hamster ovary cells of a mutant cDNA encoding endothelial ACE in which the bases coding for the C-terminal 47 amino acids, including the putative transmembrane domain, had been deleted resulted in the secretion of a soluble form of ACE (Wei et al., 199 la) . Similarly, the expression of mutants of testicular ACE lacking the C-terminal hydrophobic domain resulted in the production of a soluble, secreted form of this isoenzyme (Ehlers et al., 1991; Sen et al., 1991) . A recent study has shown that ACE in human intestinal membranes possesses a small cytoplasmic domain that is susceptible to trypsin cleavage (Naim, 1992) , and thus it would appear that the hydrophobic region at the Cterminus is responsible for the transmembrane anchoring of ACE.
Abbreviations used: ABTS, 2,2'-azinobis-(3-ethylbenzthiazoline-6-sulphonic acid); ACE, angiotensin-converting enzyme; Bz-Gly-His-Leu, benzylglycylhistidyl-leucine.
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Although ACE exists primarily as a membrane-bound enzyme, a soluble form is present under normal conditions in blood plasma, amniotic fluid, seminal plasma and other body fluids (reviewed in Erdos and Skidgel, 1987; Hooper, 1991) . In certain diseases such as sarcoidosis, diabetes mellitus, Gaucher's disease, leprosy and hyperthyroidism the levels of soluble ACE in plasma are known to be altered, and, in the case of sarcoidosis, the abnormally high level of ACE is used as a diagnostic aid (Studdy et al., 1983; Erd6s and Skidgel, 1987) . The enzyme in plasma appears to be catalytically identical and immunologically very similar to membrane-bound endothelial ACE (Das et al., 1977; Lanzillo and Fanburg, 1977; Lanzillo et al., 1985) . However, ACE purified from plasma is hydrophilic and is not recognized by a polyclonal antiserum raised to a synthetic peptide corresponding to the 20 cytoplasmic C-terminal amino acids of endothelial ACE (Wei et al., 1991a) , indicating that it probably lacks the C-terminal hydrophobic anchoring domain. However, the mechanism of production of the soluble form of ACE in normal and disease situations is unknown. While studying the membrane anchorage of pig kidney ACE, we observed that the enzyme could be released from the membrane in a soluble form by an EDTA-sensitive secretase . The released ACE was hydrophilic as assessed by phase separation in Triton X-1 14 and its failure to reconstitute into artificial lipid vesicles. In the present study we have further characterized the secretase activity which is capable ofpost-translationally cleaving membrane-bound ACE to generate a catalytically active, soluble form of the enzyme.
EXPERIMENTAL Materials
Pig tissues were kindly provided by ASDA Farmstores, Lofthousegate, W. Yorkshire, U.K. and were obtained within 10 min of death. Adult male New Zealand white rabbits (2-3 kg) were used to raise polyclonal antibodies and were provided and maintained by the University of Leeds Animal Service. Biotinylated rabbit immunoglobulin from donkey and streptavidinbiotinylated horseradish peroxidase complex were purchased from Amersham International, Aylesbury, Bucks., U.K. 2,2'-Azinobis(3-ethylbenzthiazoline-6-sulphonic acid) (ABTS), benzylglycylhistidylleucine (Bz-Gly-His-Leu), Triton X-1 14, benzamidine, iodoacetamide, p-chloromercuriphenylsulphonic acid and phenylmethanesulphonyl fluoride were obtained from Sigma Chemical Co., Poole, Dorset, U.K. Triton X-1 14 was precondensed before use (Bordier, 1981) . EDTA and EGTA were purchased from BDH, Poole, Dorset, U.K. 1,10-Phenanthroline was purchased from Aldrich Chemicals, Gillingham, U.K. a2-Macroglobulin was purchased from Boehringer-Mannheim, Purfficatlon of ACE ACE was purified from pig kidney or plasma by a modification of the method described in Hooper et al., (1987) using lisinopril--2.8 nm-Sepharose as the affinity resin. The major difference was that bound enzyme was eluted with 50 mM Na2B407/0.1% (w/v) Triton X-100, pH 9.5 (Ehlers et al., 1986) instead of using free lisinopril.
Enzyme assays ACE enzymic activity was determined with Bz-Gly-His-Leu (5 mM) as substrate in 0.1 M Tris/HCl, 0.3 M NaCl, 10 1tM ZnCl2, pH 8.3. Reactions were terminated by heating at 100°C for 5 min, and the substrate and reaction products resolved and quantified by reverse-phase h.p.l.c. as described by . Alkaline phosphatase was assayed with p-nitrophenyl phosphate as substrate, cathepsin C with L-histidyl-L-serine 2-naphthylamide as substrate, and NADPH-cytochrome c reductase and succinate dehydrogenase with 2,6-dichlorophenol indophenol as acceptor as described in Booth and Kenny (1974) .
This was a modification of the methods described previously (Lanzillo and Fanburg, 1982; Dasarathy et al., 1990; Hooper et al., 1991) . Affinity-purified pig kidney ACE was diluted in freshly prepared 0.05 M carbonate buffer, pH 9.6, and added to each well of a 96-well microtitre plate (100 ng of protein/well). The plates were rocked for 10 min at room temperature before incubation overnight at 4 'C. The wells were then washed twice with PBS (2 mM NaH2PO4/20 mM Na2HP04/0.25 M NaCl, pH 7.4), filled with 1 % (w/v) BSA, and incubated for 3 h at room temperature. The wells were then washed four times with PBS, filled with PBS and stored at 4 'C. A polyclonal antibody raised to affinity-purified pig kidney ACE was diluted 1: 30000 in 0.1 % (w/v) BSA in PBS and incubated with either known amounts of purified ACE (for a standard curve), or the phase-separated membrane samples for 6 h at 37 'C. The samples were centrifuged at 8800 g for 10 min and triplicate aliquots (0.1 ml) transferred to the coated microtitre plate wells and incubated overnight at 4 'C. The wells were then washed twice with PBS, twice with PBS containing 0.05 % (v/v) Tween 20, and finally twice with PBS. Biotinylated rabbit immunoglobulin [1:750 dilution in 0.1 % (w/v) BSA in PBS] was added to each well and incubated for 1 h at 37 'C. After washing as before, bound antibodies were detected with streptavidinbiotinylated horseradish peroxidase complex [1:1500 dilution in 0.1 % (w/v) BSA in PBS] and incubated for 1 at 37 'C. The wells were washed as before and the assay developed with 1 mM ABTS in 0.2 M citrate/sodium phosphate buffer, pH 4.3, containing 0.05 % (v/v) H202 After incubation at 23 'C in the dark, the reaction was terminated by the addition of 0.01 % (w/v) NaN3 in 0.1 M citric acid and the absorbance was measured at 405 nm in an Anthos 2001 micro-titre plate reader. The e.l.i.s.a. detected purified pig kidney ACE with a sensitivity of 32 ng per ml.
Membrane preparations All operations were carried out at 4 'C. Microvilli were prepared from kidney cortex by the method of Booth and Kenny (1974) , except that the 15000 g centrifugation steps were each extended from 12 min to 15 min, and from intestine by the method of Kessler et al. (1978) . Crude microsomal membranes were prepared from lung, placenta and testis by homogenization in 10 vol. of 0.32 M sucrose/50 mM Hepes/NaOH, pH 7.4 and the homogenate centrifuged at 8000 g for 15 min. The supernatant was then centrifuged at 26000 g for 2 h and the resulting microsomal pellet resuspended in 10 mM Hepes/NaOH, pH 7.4: (Bordier, 1981 lmmunoelectrophoretic-blot analysis SDS/PAGE was performed with a 7-17 % (w/v) polyacrylamide gradient as described previously (Relton et al., 1983 (Figure 1 ). The effect of pH on the release of ACE from pig kidney Table 2 Determinaton of the membrane-association of the activity that releases ACE from pig kidney microvillar membranes Pig kidney microvillar membranes (160 ,ug of protein) were washed five times by resuspension in 10 mM Hepes, pH 7.4 in the absence or presence of 0.5 M NaCI followed by centrifugation at 31000 g for 90 min. The membranes were finally resuspended in 0.2 M Tris/maleate, pH 8.4, incubated for 2 h at 37 OC and the release of ACE quantified by measuring enzyme activity in the detergent-rich and aqueous phases following phase separation in Triton X-114 (Figure 2 ). The release process displayed a pH optimum of 8.4. The activity that releases ACE from the membrane was enriched in the microvillar membranes to a similar extent as both ACE itself and alkaline phosphatase, another microvillar membrane marker (Table 1) . In contrast the mitochondrial marker, succinate dehydrogenase, the lysosomal marker, cathepsin C, and the endoplasmic reticulum marker, NADPH-cytochrome c reductase, were not enriched in the microvillar membrane preparation, in agreement with previous results (Booth and Kenny, 1974) . The membrane association of the releasing activity was then investigated (Table   2) NaCl. Under the same conditions no significant decrease in the amount of ACE activity associated with the membranes was observed.
Effect of protease Inhibitors on the release of ACE from pig kidney microvillar membranes
The effect of protease inhibitors on the release of ACE from pig kidney microvillar membranes was examined (Table 3 ). The release of ACE was not affected by a2-macroglobulin, nor by inhibitors of serine-, thiol-or aspartic-proteases, and the reducing agents dithiothreitol and 2-mercaptoethanol also had no inhibitory effect. However, the chelating agents EDTA and 1,10-phenanthroline (at 5 mM), caused significant (> 97 %) inhibition of the release of ACE from the membranes. In contrast, EGTA (at 5 mM) caused maximally 15 % inhibition of the release of ACE. The differential inhibition of the release of ACE by EDTA and EGTA was examined in more detail (Figure 3 ). EDTA caused 50 % inhibition of the release process at a concentration of 2.5 mM, whereas EGTA caused maximally 15 % inhibition at a concentration of 10 mM. The release of ACE from the membranes was not inhibited by the potent inhibitors of ACE, captopril, enalaprilat and zofenoprilat, nor by the inhibitors of endopeptidase-24. 1I (EC 3.4.24.11), phosphoramidon and thiorphan (Table 3) . The aminopeptidase inhibitors, amastatin, bestatin and puromycin also had no inhibitory effect on the release of ACE (results not shown). Figure 4 Immunoelectrophoretic blot of the ACE released from pig microvillar membranes and ACE purffmed from plasma Pig kidney microvillar membranes (160 ug of protein) were incubated in 0.2 M Tris/maleate (pH 8.4) in the absence or presence of EDTA (5 mM) for 2 h at 37°C. After phase separation in Triton X-114, the detergent-rich and aqueous phases were subjected to SDS/PAGE and immunoelectrophoretic-blot analysis as described in the Experimental section with a polyclonal antiserum raised to ACE purified from pig kidney . Bound antiserum was detected with a 1251-labelled second antibody followed by autoradiography. Lane 1, ACE purified from pig plasma (2.5 ug of protein); lane 2, aqueous phase after incubation of microvillar membranes in the absence of EDTA; lane 3, detergent-rich phase after incubation of microvillar membranes in the absence of EDTA; lane 4, aqueous phase after incubation of microvillar membranes in the presence of EDTA; lane 5, detergent-rich phase after incubation of microvillar membranes in the presence of EDTA; lane 6, ACE purified from pig kidney after solubilization by incubating membranes at 37 OC (2.5 ,ug of protein).
Tissue distribution of the activity that releases ACE from the membrane Other pig and human tissues which are relatively rich in ACE were examined for the presence of the activity releasing ACE from the membrane (Table 5) . ACE was also released from pig lung and testicular microsomal membranes to a similar extent as from pig kidney microvillar membranes, and in both cases this release was inhibited significantly (> 69 %) by EDTA. In contrast to the pig, no significant EDTA-sensitive release of ACE was observed from human kidney microvillar membranes. However, ACE was released from both human lung and placental microsomal membranes, and in both cases the release was inhibited significantly (> 73 %) by EDTA. Negligible EDTA-sensitive release of ACE was observed from either pig or human duodenal and jejunal brush-border membranes.
Comparison of the form of ACE released from pig kidney microvillar membranes with ACE purified from plasma Pig kidney microvillar membranes were incubated at 37°C and the resultant aqueous and detergent-rich phases were subjected to SDS/PAGE and immunoelectrophoretic-blot analysis with a polyclonal antiserum raised to purified pig kidney ACE ( Figure  4) . The ACE released from the microvillar membranes ( Figure 4 , lane 2) was recognized by the antiserum and co-migrated with ACE purified from pig plasma (Figure 4 , lane 1) and with ACE purified from pig-kidney cortex following its solubilization by incubation of the membranes at 37 IC (Figure 4 , lane 6). Less immunoreactive ACE was observed in the aqueous phase after the microvillar membranes had been incubated in the presence of EDTA (Figure 4 , lane 4).
DISCUSSION
While establishing that ACE was anchored to the plasma membrane through its C-terminus , we observed that the enzyme could be released into the high-speed supernatant from pig kidney microsomal membranes upon incubation at neutral pH and at 37 'C. ACE was one of only several cell-surface integral membrane proteins so released. We also observed that the release of ACE appeared to be inhibited by EDTA. As ACE is itself inhibited by this chelating agent it was necessary to establish a method for the quantification of ACE that was independent of its enzyme activity. A competitive e.l.i.s.a. was therefore established using a polyclonal antiserum raised to affinity-purified pig kidney ACE to quantify enzyme protein. This antiserum also crossreacts with the smaller testicular isoenzyme (Williams et al. 1992) . We also chose to use phase separation in Triton X-1 14 (Bordier, 1981) to distinguish between the amphiphatic, membrane-bound form of ACE and the hydrophilic, soluble form rather than high-speed centrifugation as it is more rapid. After phase separation in Triton X-1 14, ACE in the detergent-rich and aqueous phases was accurately and reproducibly quantified by the e.l.i.s.a., the results correlating well with those obtained from measurements of enzyme activity (Figure 1 ). The release of ACE from purified pig kidney microvillar membranes by the secretase activity was optimal at 37 'C (results not shown), and negligible at 4 'C (Figure 1 ), and displayed a pH optimum of 8.4 (Figure 2 ). The relative lack of contamination of the microvillar enzyme preparation by lysosomal, mitochondrial and endoplasmic reticulum marker enzymes and the co-enrichment of the secretase activity with the microvillar membrane markers alkaline phosphatase and ACE itself (Table 1) , would indicate that the presence of the secretase activity is almost certainly not due to contamination of the microvillar membranes by other membrane fractions but that the secretase activity is probably a component of the microvillar membrane. To assess whether the secretase activity was a soluble or peripheral membrane protein, the microvillar membranes were further washed extensively with 0.5 M NaCl (Table 1) . No reduction was observed in the amount of ACE released, indicating that the secretase activity that is responsible for the release of ACE is tightly membrane associated, possibly an integral membrane protein.
To determine the class of protease that the ACE secretase belongs to, we examined the effect of class-specific protease inhibitors on the release of ACE from pig kidney microvillar membranes (Table 3 ). The general protease inhibitor a2-macroglobulin and inhibitors of serine-, thiol-and aspartic-proteases had no effect on the release of ACE. In contrast, the metal chelators, EDTA and 1,10-phenanthroline, caused significant inhibition of the secretase activity. The inhibition by EDTA could be reversed by Mg2+ ions, and to a lesser extent by Zn2+ and Mn2+ ions (Table 4 ). The lack of significant inhibition by EGTA (Figure 3 ) and the observation that Mg2+ ions were the most effective at reversing the inhibition by EDTA, indicate that the secretase activity is possibly a Mg2+-dependent metalloprotease. The lack of inhibition of the secretase by a range of ACE inhibitors indicates that the release is not due to an autocatalytic event, and the failure of either phosphoramidon or thiorphan to cause significant inhibition indicates that endopeptidase-24.11 also is not responsible.
A survey of other tissues which are relatively rich in membranebound ACE (Table 5) revealed that, in addition to pig kidney, ACE in both pig and human lung, human placenta and pig testis could be released in a soluble form by an EDTA-sensitive activity at pH 8.4 and 37 'C. In contrast, no significant release of ACE was observed from human kidney or human and pig intestinal microvillar membranes. Membrane-bound endothelial ACE in the lungs is a probable source under normal circumstances of most of the soluble form of ACE in plasma, by virtue of both the high activity of ACE in, and the enormous passage of blood through, this organ (Erdos and Skidgel, 1987) . As the form of ACE released from the pig kidney microvillar membranes by the EDTA-sensitive secretase co-migrated on SDS/PAGE with ACE purified from plasma (Figure 4) , the presence of the secretase activity in lung microsomal membranes would possibly be consistent with it having a role in the normal physiological generation of the soluble form of ACE in plasma. The presence of the secretase activity in microsomal membranes from testis and placenta and in microvillar membranes from kidney would suggest that the enzyme may have a role in the generation from membrane-bound ACE of the soluble form of ACE found in seminal plasma, amniotic fluid and urine respectively.
Much interest has been focused recently on the family of matrix-degrading metalloproteinases, e.g. collagenase, stromelysin, etc (reviewed in Matrisan, 1990; Woessner, 1991) . These proteases degrade extracellular matrix and basement-membrane components and may play important roles in normal processes and in pathological conditions. The matrix-degrading metalloproteinases are characteristically soluble secreted proteins, contain Zn2+, and are inhibited by chelating agents and by specifictissue inhibitors of metalloproteinases. Although the secretase activity characterized in the present study is sensitive to certain chelating agents, it differs from the matrix-degrading metalloproteinases in being tightly membrane-associated, possibly Mg2+-dependent, and insensitive to inhibition by a2-macroglobulin.
Several other candidate secretase activities have been identified (reviewed in Ehlers and Riordan, 1991 b) ; however, only a few are metalloproteases and only one has been characterized in sufficient detail to indicate that it may be similar to the activity described in the present study. A Mg2+-dependent, EDTAsensitive protease has been detected in human placental chorionic villi and rat kidney homogenates which appears to be responsible for the release in a soluble active form of the transmembrane folate receptor (Antony et al., 1989; Elwood et al., 1991; Verma and Antony, 1991) . However, a recent report (Verma et al., 1992) demonstrated the lack of this Mg2+-dependent protease in extensively washed placental membranes, suggesting that the protease is either soluble or a loosely attached peripheral membrane protein, which contrasts with the integral membrane nature of the ACE secretase described in the present study.
In conclusion, we have developed a reproducible, sensitive and rapid assay based on phase separation in Triton X-1 14 and a competitive e.l.i.s.a. to characterize the process that releases hydrophobic membrane-bound ACE into a soluble, hydrophilic form. This secretase activity is enriched in pig kidney microvillar membranes, is tightly membrane-associated, has a neutral pH optimum, and on the basis of inhibitor and bivalent cation studies appears to be a Mg2+-dependent metalloprotease. The secretase is also present in microsomal membranes prepared from pig lung and testis, and human lung and placenta, and is thus a candidate for the mechanism that generates the soluble
